Navigation Links
How do anticancer drugs work?
Date:5/3/2013

RIVERSIDE, Calif. Anticancer drugs save lives and/or improve the quality of life for many cancer patients. Many anti-cancer drugs work by killing tumor cells after inducing damage to DNA.

The public has an opportunity to learn about the mechanisms of action of some commonly used anticancer drugs and how laboratory research may lead to novel targets and new strategies for cancer treatment.

Yinsheng Wang, a professor of chemistry at the University of California, Riverside, will give a free lecture on May 16 on campus to discuss those drugs that induce damage to DNA, as well as those biomolecules that allow for selective targeting of tumor cells. He will also discuss the implications of personalized medicine in cancer treatment.

Wang's hour-long talk is titled "Curing cancer: How do anticancer drugs work?" It will begin at 5:30 p.m. in Rooms C, D and E, University Extension Center (UNEX). Seating is open. Parking at UNEX is free for lecture attendees.

The lecture is the third in the annual Science Lecture Series hosted by the College of Natural and Agricultural Sciences (CNAS). This year the theme is "The Science of Disease." The series aims to boost the public's awareness and understanding of science and of how scientists work.

"Anti-cancer drugs induce their cytotoxic effects via different molecular targets," Wang said. "Patients' genetic make-up can have a significant effect on the clinical efficacies of anti-tumor drugs. Innovative technologies may lead to the discovery of new molecular targets that can be used for more effective treatment of cancer while minimizing side effects."


'/>"/>
Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. 11th International Congress on Targeted Anticancer Therapies
2. Harnessing anticancer drugs for the future fight against influenza
3. High levels of TRAIL protein in breast milk might contribute to anticancer activity
4. Mapping of cancer cell fuel pumps paves the way for new drugs
5. Co-Q10 deficiency may relate to concern with statin drugs, higher risk of diabetes
6. Cholesterol rafts deliver drugs inside cancer cells
7. Findings to help in design of drugs against virus causing childhood illnesses
8. KU Leuven lab coordinates €9m effort to find new deep-sea drugs
9. Mood-modifying drugs for humans also alter fish behavior
10. Study finds potential to match tumors with known cancer drugs
11. £6.5M in funding to help manufacture the drugs of the future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 18, 2014 Research and Markets ... "Micro Market Monitor: North America Perimeter Security Systems ... http://photos.prnewswire.com/prnh/20130307/600769 The North American ... CAGR of 3.6% from 2014 to 2019. Although the ... Canada is expected to grow ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and Markets ... addition of the "Samsung Galaxy S5 - ... report to their offering. ... totally different sensing technology than the iPhone 5S, ... sensor in its product. The Galaxy ...
(Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
Breaking Biology News(10 mins):Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... 2012; Wiley-Blackwell, the scientific, technical, medical and scholarly publishing ... two new interdisciplinary review publications: WIREs Developmental Biology ... WIREs Developmental Biology will focus on ... fully patterned adult organism. Edited by John C. Gerhart ...
... for Molecular Medicine (MDC) Berlin-Buch and of the Excellence Cluster ... the Helmholtz Association over the next two years. The grant ... to treat diseases that are caused by protein misfolding. These ... by the MDC, a member institution of the Helmholtz Association, ...
... BOSTON (February 23, 2012, 5:00 pm ET) Researchers ... in vitro and in vivo study, published today in ... stimulates the growth of blood vessels and promotes re-growth of ... new treatment for chronic and acute wounds. The ...
Cached Biology News:Wiley-Blackwell launches 2 interdisciplinary review titles in developmental and membrane biology 2Accelerated search for active agents to treat Alzheimer's and Parkinson's 2Novel bioactive peptides promote wound healing in vivo 2Novel bioactive peptides promote wound healing in vivo 3
(Date:12/19/2014)... 18, 2014 LayerBio is an MIT ... wound care. The National Eye Institute (NEI) at the ... Phase I SBIR grant to develop a drug-eluting intraocular ... most common cause of vision loss in people over ... According to Dr. Ken Mandell, LayerBio’s Founder and CEO, ...
(Date:12/19/2014)... The empty capsules market is experiencing ... and technological innovations in the empty capsules market. ... the growth of the empty capsules market. , ... Scope of Report , The report will enrich ... firms to gauge the pulse of the market ...
(Date:12/19/2014)... 18, 2014 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced the results of its annual ... was a transformational year in Relmada,s history and it ... company," said Sergio Traversa , chief executive officer ... on key financial, human resource and clinical development objectives ...
(Date:12/17/2014)... 2014 Ipsen Biopharmaceuticals, Inc., an ... IPSEY), today announced that Somatuline® Depot® ... was approved by the U.S. Food and Drug ... tumors (GEP-NETs) in adult patients with unresectable, well ... to improve progression-free survival (PFS). , “The approval ...
Breaking Biology Technology:LayerBio Awarded NIH Grant to Develop a Drug Delivery Device for Cataract Surgery 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8
... Technology Inc. , the company whose automated computer system ... extending its market reach with a new acquisition. , ... based here, acquired Equipsoft Corp. , a Knoxville, ... ,"Equipsoft offers a complementary product line. The combined enterprises ...
... - Speaking at last week's state biotechnology conference, former governor ... a man with higher office on his mind. Make that ... of Wisconsin in 1998 and who resigned as U.S. ... disgruntled with the Bush White House , would ordinarily ...
... Department of Commerce has qualified seven small ... Investor and Venture Fund Tax Credit programs. , ... technology and biotechnology companies, offer Wisconsin income tax credits ... funds. People that invest in qualified businesses can claim ...
Cached Biology Technology:Eagle Technology acquires some synergy 2Tommy Thompson's Iowa strategy isn't far-fetched 2Tommy Thompson's Iowa strategy isn't far-fetched 3Tommy Thompson's Iowa strategy isn't far-fetched 4Commerce qualifies seven for investor tax credits 2
...
...
... cytostatic and anti-viral agent. Inhibits several important steps ... formation of HUVEC cells. Also reduces intracellular reactive ... IL-8 release of endothelial cells. ... 16 O 8 MolWeight: ...
For mRNA Differential Display with three one-base anchored oligo-dT primers and rationally designed arbitrary 13mers. These kits feature the latest generation of isotopic mRNA Differential Display t...
Biology Products: